United States· US:84761-0004_471d2c84-a0bf-6b07-e063-6294a90a4740
MEnera
A medicinal product containing allicin; lepidium meyenii root; ubiquinol, registered in United States by Tejeda Enterprises Incorporated.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ALLICIN; LEPIDIUM MEYENII ROOT; UBIQUINOL
- Manufacturer
- Tejeda Enterprises Incorporated
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 5, 2026
Packs & prices · 2
- ndc11847610004160 U in 1 CAPSULE (84761-0004-1)
- ndc1184761-0004-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4a81ee9-ea22-4deb-b37a-2da33466bbd1 GET /v1/drugs/f4a81ee9-ea22-4deb-b37a-2da33466bbd1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1200; 500; 100",
"substance": "ALLICIN; LEPIDIUM MEYENII ROOT; UBIQUINOL",
"productndc": "84761-0004",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/2U; mg/2U; mg/2U",
"application_number": "M027",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about allicin; lepidium meyenii root; ubiquinol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.